Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Biedermann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Thrombosis and Haemostasis|March 4, 2022
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K AntagonistsChantal Visser, Joseph S Biedermann, Melchior C Nierman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrateMarjolein P A Brekelmans, Rahat A Abdoellakhan, Luuk J J Scheres, et al.
Research and Practice in Thrombosis and Haemostasis|March 16, 2023
Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trialEleonora Camilleri, Nienke van Rein, Bart J M van Vlijmen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2016
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort studyJ S Biedermann, N van Rein, A M H P van den Besselaar, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2018
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trialFernanda A Orsi, Joseph S Biedermann, Marieke J H A Kruip, et al.
British Journal of Haematology|April 18, 2020
Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trialSuzanne Schol-Gelok, Moniek P M de Maat, Joseph S Biedermann, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Thrombosis and Haemostasis|March 4, 2022
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K AntagonistsChantal Visser, Joseph S Biedermann, Melchior C Nierman, et al.
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Clinical outcome of patients with a vitamin K antagonist-associated bleeding treated with prothrombin complex concentrateMarjolein P A Brekelmans, Rahat A Abdoellakhan, Luuk J J Scheres, et al.
Research and Practice in Thrombosis and Haemostasis|March 16, 2023
Influence of rosuvastatin on apolipoproteins and coagulation factor levels: Results from the STAtin Reduce Thrombophilia trialEleonora Camilleri, Nienke van Rein, Bart J M van Vlijmen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2016
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort studyJ S Biedermann, N van Rein, A M H P van den Besselaar, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2018
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trialFernanda A Orsi, Joseph S Biedermann, Marieke J H A Kruip, et al.
British Journal of Haematology|April 18, 2020
Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trialSuzanne Schol-Gelok, Moniek P M de Maat, Joseph S Biedermann, et al.
Pageof 3